Glenmark Pharma Included In Dow Jones Sustainability Index For The Third Year In A Row

For the third consecutive year in a row, Glenmark Pharmaceuticals Ltd announced that it has been listed in the Dow Jones Sustainability Index (DJSI), under the category of emerging markets.

DJSI is one of the world's most respected and widely accepted sustainability benchmarks globally. Inclusion in this list is considered highly prestigious by global investors, financial analysts and other stakeholders and serves as a benchmark for investors who integrate sustainability considerations into their portfolios.

The DJSI analyses companies on their corporate economic, environmental and social performance, to assess issues such as but not limited to corporate governance, risk management, environmental policy & management systems, supply chain management, occupational health and safety, labour practices, innovation and cybersecurity amongst others.

"DJSI is universally acknowledged as one of the most respected and accepted sustainability benchmarks and so it is a matter of great pride for us to be included in the list for the third consecutive year. We recognize that sustainability is a continual process that encompasses our operations, stakeholders, communities and the planet at large. Our inclusion in this list underscores our consistent performance across all sustainability indicators," said Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals.

Shares of the company were trading around one percent higher after the announcement.